Cargando…
Combined Serum DKK3 and Circulating CD133 Cells as Prognostic Biomarkers for Ovarian Cancer Patients
INTRODUCTION: Ovarian cancer (OV) can seriously endanger women’s physical and mental health. Serum DKK3 has been used for the diagnosis and prognosis of patients with ovarian cancer. However, the specificity of antibodies may lead to errors in the detection of plasma protein. METHODS: Circulating CD...
Autores principales: | Nie, Xiao-Cui, He, Fang, Lan, Chong, Niu, Ju-Min, Xia, Pu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814242/ https://www.ncbi.nlm.nih.gov/pubmed/33488097 http://dx.doi.org/10.2147/OTT.S288191 |
Ejemplares similares
-
Prognostic value of DKK2 from the Dickkopf family in human breast cancer
por: Shao, You-Cheng, et al.
Publicado: (2018) -
CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009) -
The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis
por: Chen, Engeng, et al.
Publicado: (2016) -
Prognostic value of CD133(+)
CD54(+)
CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017) -
CD133 in brain tumor: the prognostic factor
por: Li, Bin, et al.
Publicado: (2016)